Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients

被引:50
作者
Jeon, Min-Hyok [3 ]
Choi, Sang-Ho [1 ,2 ]
Kwak, Yee Gyung [1 ,2 ]
Chung, Jin-Won [1 ,2 ]
Lee, Sang-Oh [1 ,2 ]
Jeong, Jin-Yong [1 ,2 ,4 ]
Woo, Jun Hee [1 ,2 ]
Kim, Yang Soo [1 ,2 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Div Infect Dis, Seoul 138736, South Korea
[2] Univ Ulsan, Ctr Antimicrobial Resistance & Microbial Genet, Seoul 138736, South Korea
[3] Soonchunhyang Univ, Coll Med, Dept Infect Dis, Choongchungnam Do 336745, South Korea
[4] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea
关键词
Carbapenem; Resistance; Escherichia coli;
D O I
10.1016/j.diagmicrobio.2008.08.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Carbapenem resistance among Gram-negative bacilli has become an increasingly serious problem worldwide, and the emergence and spread of carbapenem-resistant Escherichia coli (CREC) is also becoming a serious problem. To date, however, risk factors for CREC acquisition have not been determined, so we decided to evaluate this in hospitalized patients through matched case-control study. Nosocomially acquired CREC was isolated from 46 patients between January 1997 and December 2007. For each patient, 3 matched-control subjects were selected. Previous use of carbapenem (adjusted odds ratio [AOR]. 6.50) and metronidazole (AOR, 4.25), the presence of biliary drainage catheter (AOR, 4.59), and prior hospital stay (AOR 1.02) were found as independent risk factors for CREC. Our results suggest that the nosocomial acquisition of CREC may be favored by the selection pressure of carbapenems and metronidazole and also related to prior hospital stay and the presence of biliary drainage catheter. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 27 条
[1]   Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York [J].
Bratu, Simona ;
Brooks, Steven ;
Burney, Sibte ;
Kochar, Sandeep ;
Gupta, Jyoti ;
Landman, David ;
Quale, John .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (07) :972-975
[2]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[3]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133
[6]  
GAYNES RP, 1992, INFECT CONT HOSP EP, V13, P10, DOI 10.1086/646417
[7]   Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss [J].
Guelmez, Dolunay ;
Woodford, Neil ;
Palepou, Marie-France I. ;
Mushtaq, Shazad ;
Metan, Gokhan ;
Yakupogullari, Yusuf ;
Kocagoz, Sesin ;
Uzun, Omrum ;
Hascelik, Gulsen ;
Livermore, David M. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (06) :523-526
[8]   Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review [J].
Harris, AD ;
Karchmer, TB ;
Carmeli, Y ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) :1055-1061
[9]   Control-group selection importance in studies of antimicrobial resistance:: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli [J].
Harris, AD ;
Samore, MH ;
Lipsitch, M ;
Kaye, KS ;
Perencevich, E ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1558-1563
[10]   Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients [J].
Harris, AD ;
Perencevich, E ;
Roghmann, MC ;
Morris, G ;
Kaye, KS ;
Johnson, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :854-858